WO2005116651A3 - Procede et dispositif de detection de la presence de la proteine de bence-jones - Google Patents

Procede et dispositif de detection de la presence de la proteine de bence-jones Download PDF

Info

Publication number
WO2005116651A3
WO2005116651A3 PCT/US2005/018257 US2005018257W WO2005116651A3 WO 2005116651 A3 WO2005116651 A3 WO 2005116651A3 US 2005018257 W US2005018257 W US 2005018257W WO 2005116651 A3 WO2005116651 A3 WO 2005116651A3
Authority
WO
WIPO (PCT)
Prior art keywords
testing
bjp
urine
unspun
screening
Prior art date
Application number
PCT/US2005/018257
Other languages
English (en)
Other versions
WO2005116651A2 (fr
Inventor
Gregory Witchel
G Berry Schumann
Todd M Dematteo
John Liseo
Paul C Reardon
Original Assignee
Diasys Corp
Gregory Witchel
G Berry Schumann
Todd M Dematteo
John Liseo
Paul C Reardon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diasys Corp, Gregory Witchel, G Berry Schumann, Todd M Dematteo, John Liseo, Paul C Reardon filed Critical Diasys Corp
Publication of WO2005116651A2 publication Critical patent/WO2005116651A2/fr
Publication of WO2005116651A3 publication Critical patent/WO2005116651A3/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G01N33/54389—Immunochromatographic test strips based on lateral flow with bidirectional or multidirectional lateral flow, e.g. wherein the sample flows from a single, common sample application point into multiple strips, lanes or zones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5023—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures with a sample being transported to, and subsequently stored in an absorbent for analysis

Abstract

L'invention concerne une méthode, un dispositif et diverses trousses d'immunodétection spécifique de chaînes légères libres dans un échantillon d'urine non traité. La méthode, le dispositif et les trousses de l'invention peuvent être utilisés pour effectuer un criblage destiné à identifier un état pathologique produisant la protéine de Bence-Jones. La méthode consiste à chercher à détecter la présence de la protéine de Bence-Jones dans de l'urine non brassée, non centrifugée. La méthode, le dispositif et les trousses de l'invention peuvent être utilisés pour surveiller et effectuer des essais complémentaires visant à détecter de tels états pathologiques. Un dispositif in vitro (IVD) peut effectuer la détection de chaînes légères d'urine non brassée (BJP). Ce dispositif peut être un matériel de dosage IVD, un tube (comme ceux utilisés dans un laboratoire clinique ou un cabinet de médecin, notamment) incorporant une bande de réactif, ou une cassette utilisant une technologie d'écoulement latéral (ladite cassette pouvant être utilisée pour effectuer des essais à la maison ou sur le lieu d'administration des soins, notamment). Le dispositif est efficace pour tous les usages énumérés ci-dessous se rapportant aux états pathologiques évoqués produisant la BJP décelable par le dispositif: criblage, surveillance, et essai complémentaire. On décrit une méthode de criblage destinée à détecter un état pathologique produisant la BJP, qui consiste à effectuer un essai visant à détecter la présence de la BJP dans de l'urine non brassée, non centrifugée. On décrit également d'autres méthodes similaires de surveillance et d'essai complémentaire visant à détecter de tels états pathologiques.
PCT/US2005/018257 2004-05-24 2005-05-24 Procede et dispositif de detection de la presence de la proteine de bence-jones WO2005116651A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57391404P 2004-05-24 2004-05-24
US60/573,914 2004-05-24

Publications (2)

Publication Number Publication Date
WO2005116651A2 WO2005116651A2 (fr) 2005-12-08
WO2005116651A3 true WO2005116651A3 (fr) 2006-10-05

Family

ID=35451509

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/018257 WO2005116651A2 (fr) 2004-05-24 2005-05-24 Procede et dispositif de detection de la presence de la proteine de bence-jones

Country Status (1)

Country Link
WO (1) WO2005116651A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0501741D0 (en) * 2005-01-27 2005-03-02 Binding Site The Ltd Antibody
CN101261270B (zh) * 2007-03-09 2012-11-07 中国人民解放军军事医学科学院微生物流行病研究所 一种免疫层析多重检测试纸盘及免疫层析多重检测方法
EP2058663A1 (fr) * 2007-11-12 2009-05-13 Euro-Diagnostica B.V. Procédé pour l'immobilisation d'un analyte sur un support solide
GB0819720D0 (en) * 2008-10-28 2008-12-03 Univ Birmingham Methods and products
GB201001950D0 (en) * 2010-02-05 2010-03-24 Binding Site Group The Ltd Infection prognostic assay
GB2478520A (en) * 2010-03-02 2011-09-14 Binding Site Group Ltd Kidney prognostic assay
GB201012049D0 (en) * 2010-07-19 2010-09-01 Binding Site Group The Ltd Competition assay
CN103698284B (zh) * 2013-09-03 2015-07-15 柏荣诊断产品（上海）有限公司 一种测定Lambda游离轻链浓度的试剂盒及方法
CN103728455B (zh) * 2013-09-03 2015-07-15 柏荣诊断产品（上海）有限公司 一种测定Kappa游离轻链浓度的试剂盒及方法
EP3347448B1 (fr) 2015-09-09 2020-07-08 Drawbridge Health, Inc. Procédés pour le prélèvement, la stabilisation et la conservation d'échantillons
US10610862B2 (en) * 2016-04-04 2020-04-07 Advance Dx, Inc. Multiple path sample collection card
EP3465139A4 (fr) * 2016-05-23 2020-01-22 Vanderbilt University Dispositifs, kits et procédés de surveillance d'états pathologiques
CN107727850B (zh) * 2017-10-10 2021-08-27 常州博闻迪医药股份有限公司 一种侧向流层析检测反应启动控制方法
CN107290540A (zh) * 2017-06-22 2017-10-24 中国农业大学 大肠杆菌o157:h7和鼠伤寒沙门氏菌共检测试纸及其制备方法与应用
EP3816626A1 (fr) * 2019-10-30 2021-05-05 Feral GmbH Agencement de test de flux latéral approprié pour la détection d'un analyte dans la salive
IT202000006694A1 (it) * 2020-03-31 2021-10-01 Bioci Di Ciaiolo Carlo Procedimento per la rivelazione di componenti immunoglobuliniche monoclonali in un fluido biologico e relativo kit

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020182748A1 (en) * 2001-03-30 2002-12-05 Reardon Paul C. Method and device for testing for Bence-Jones Protein

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020182748A1 (en) * 2001-03-30 2002-12-05 Reardon Paul C. Method and device for testing for Bence-Jones Protein

Also Published As

Publication number Publication date
WO2005116651A2 (fr) 2005-12-08

Similar Documents

Publication Publication Date Title
WO2005116651A3 (fr) Procede et dispositif de detection de la presence de la proteine de bence-jones
KR101982332B1 (ko) 단계 간단화, 소량 샘플, 속도 가속화, 사용이 용이한 생물화학 측정장치 및 방법
DK2082226T3 (da) Sekventiel analyse af biologiske prøver
WO2006026020A3 (fr) Fibronectine oncofoetale en tant que marqueur de maladies et d'autres conditions et procedes pour la detection de la fibronectine oncofoetale
WO2006126008A3 (fr) Procedes d'immuno-essais ameliores
DK1322960T3 (da) Allergen-mikroarrayassay
KR20190057445A (ko) 샘플 특히 혈액샘플을 분석하기 위한 장치와 시스템 및 그 사용 방법
WO2005103698A3 (fr) Procedes et anticorps pour la detection de nitrofuranes
WO2007061793A3 (fr) Cardiolipine modifiee et ses utilisations
WO2007002579A3 (fr) Cartouches et methodes d'analyse pour instruments d'analyse delocalisee
ATE428929T1 (de) Reagens, ausstattung und verfahren zur probenanalyse
ATE402269T1 (de) Methoden und testsätze für annäherungstest
ATE524736T1 (de) Sequenzielle analyse biologischer proben mit bleichung von intermediären fluoreszenzsignalen
WO2010038974A3 (fr) Composition et trousse de diagnostic pour néphropathie à dépôts d'immunoglobulines a et néphropathie tgbm
NZ609824A (en) Immunochromatography devices, methods and kits
DE60130919D1 (de) Durchflussvorrichtung, diagnostischer kit diese enthaltend und gebrauch für den nachweis von analyten in einer probe
ATE553386T1 (de) Bluttypisierung
WO2005079420A3 (fr) Dosage d'agglutination d'exclusion chromatographique et leurs methodes d'utilisation
WO2008152528A3 (fr) Procédé de diagnostic ou de criblage d'une infection par arbovirus, réactifs utiles dans le procédé et leurs applications
WO2004015420A8 (fr) Procede de diagnostic de sclerose en plaques
WO2002016943A3 (fr) Dosage immunologique differentiel
FI20012603A (fi) Diagnostinen menetelmä
ATE447711T1 (de) System zur internen, qualitativen und quantitativen überprüfung von zellmarker-indices
EP2444812A3 (fr) Procédés améliorés de dosage immunologique
WO2012018855A3 (fr) Systèmes et procédés de dosages immuno-adsorbants pour substances à analyser uniques et multiples

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase